BACE : lead target for orchestrated therapy of alzheimer’s disease / edited by Varghese John
John, Varghese
(John Wiley and Sons, 2010)
|
| BACE (β-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE : lead target for orchestrated therapy of alzheimer's disease covers virtually all aspects of BACE from initial identification, discovery of inhibitors, and challenges in clinical development, while providing a global understanding essential for productive and successful drug discovery. |
 01-fmatter.pdf :: Unduh
|
| No. Panggil : | e20410879 |
| Entri tambahan-Nama orang : | |
| Subjek : | |
| Penerbitan : | Hoboken, New Jersey: John Wiley and Sons, 2010 |
| Sumber Pengatalogan: | |
| Tipe Konten: | |
| Tipe Media: | |
| Tipe Pembawa: | |
| Deskripsi Fisik: | |
| Tautan: | http://onlinelibrary.wiley.com/book/10.1002/9780470594087 |
| Lembaga Pemilik: | |
| Lokasi: |
| No. Panggil | No. Barkod | Ketersediaan |
|---|---|---|
| e20410879 | TERSEDIA |
| Ulasan: |
| Tidak ada ulasan pada koleksi ini: 20410879 |
